We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Eli Lilly and Co | NYSE:LLY | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-15.91 | -2.10% | 740.00 | 745.00 | 730.34 | 743.10 | 4,593,881 | 01:00:00 |
By Stephen Nakrosis
The Pentagon on Wednesday said Eli Lilly and Co. was awarded a $625 million modification to a contract for 500,000 doses of LY-CoV555, a Covid-19 therapeutic drug treatment.
The Pentagon said the work will be performed in Indianapolis, Indiana, and has an estimated completion date of Jan. 27.
The U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland, is the contracting activity, the Pentagon said.
--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
January 27, 2021 17:52 ET (22:52 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Eli Lilly Chart |
1 Month Eli Lilly Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions